GF
AMRI

Gabelli Funds’s Albany Molecular Research Inc AMRI Stock Holding History

Gabelli Funds’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-277,545
Closed -$6.02M – 1147
2017
Q2 		$6.02M Buy
+277,545
New +$5.04M 0.04% 515

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Gabelli Funds's AMRI Position: Q3 2017 in Review

Gabelli Funds sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 277,545 shares — an estimated $6.02M sold.

Gabelli Funds first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $6.02M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Gabelli Funds reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Gabelli Funds sold 277,545 Albany Molecular Research Inc shares in Q3 2017, an estimated $6.02M.
  • Gabelli Funds first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Gabelli Funds's Albany Molecular Research Inc position peaked at $6.02M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Gabelli Funds's 13F filing for Q3 2017, filed 1 Nov 2017.